Clinical Trial Update: Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL [Phase 4]

View source ↗

Summary

Phase 4 trial investigating a PD-1 monoclonal antibody in combination with chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• PD-1 monoclonal antibody

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Relapsed/Refractory Non-Hodgkin's Lymphoma | Phase 4 | Status: UNKNOWN